All Stories

  1. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered...

    Article • Vaccine, May 2013, Elsevier

    Dr Nils IA Carlin

  2. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein

    Article • Vaccine, February 2013, Elsevier

    Dr Nils IA Carlin